13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)

Page 2 of 12

Page 2 of 12 – SEC Filing

SCHEDULE 13D
CUSIP No.  221015100
1
NAME OF REPORTING PERSONS
OrbiMed Advisors LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) o
3
SEC USE ONLY
4
SOURCE OF FUNDS (See Instructions)
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
5,967,584
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
5,967,584
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,967,584
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
20.47%*
14
TYPE OF REPORTING PERSON (See Instructions)
IA
Follow Corvus Pharmaceuticals Inc.
Page 2 of 12